Cystic Fibrosis

Pathway Contributor: Genevieve Mailhot

Credentials:
PhD, RD

Contributions:

• Do individuals with cystic fibrosis (CF) who supplement their diets with omega-3 fatty acid supplements (containing eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)) have improved health outcomes compared with individuals with CF not consuming omega-3 fatty acid supplements?  

  Role: Reviewer

• What is the recommended nutrition management for the most common nutrition-related medical problems in cystic fibrosis (CF) (e.g. CF-related diabetes, low bone density)?  

  Role: Reviewer

• What type of nutrition interventions are effective in supporting optimal growth and weight gain in children and adults with cystic fibrosis? When are oral calorie supplements or enteral supplementation indicated?  

  Role: Reviewer

• What are the recommendations for pancreatic enzyme replacement therapy (PERT) in individuals with cystic fibrosis?  

  Role: Reviewer

• What are the recommendations for nutrition screening, assessment and monitoring in children and adults with cystic fibrosis?  

  Role: Reviewer

• What are the recommendations for mineral supplementation in individuals with cystic fibrosis?  

  Role: Reviewer

• Do individuals with cystic fibrosis (CF) who supplement their diets with probiotics have improved health outcomes compared with individuals with CF not using probiotics?  

  Role: Reviewer

• Do infants, children and adults with cystic fibrosis (CF) have higher energy and macronutrient requirements compared to healthy infants, children and adults without CF?  

  Role: Reviewer

• What are the recommendations for fat-soluble vitamins in individuals with cystic fibrosis?  

  Role: Reviewer

View all Pathway Contributors